News 23 February 2026

LIVEMarkets rolling coverageStarted: July 17, 2026, 4:00 AM EDTUpdated: July 17, 2026, 8:26 PM EDT CSL Limited (ASX:CSL) wrestles with US$650m revenue headwinds before August results July 17, 2026, 8:26 PM EDT. CSL Limited (ASX:CSL) is dealing with US$650 million in revenue pressures, about 4.3% of its FY26 revenue forecast, just ahead of its August 18 results. Most of this hit comes from a US immunoglobulin shortfall (US$300 million), less China albumin sales (US$200 million), and regional disruptions (US$150 million). CSL shares still closed at A$123.32 on Friday, up 1.12% and beating the S&P/ASX 200. Management is targeting cost cuts